Xiaohong Liu Selected Research

Virus Diseases (Viral Diseases)

1/2023	Pseudorabies Virus Infection Activates the TLR-NF-κB Axis and AIM2 Inflammasome To Enhance Inflammatory Responses in Mice.
10/2022	Vimentin inhibits type I interferon production by disrupting the TBK1-IKKε-IRF3 axis.
1/2022	Chlorine Dioxide Inhibits African Swine Fever Virus by Blocking Viral Attachment and Destroying Viral Nucleic Acids and Proteins.
1/2020	Lipopolysaccharide Downregulates CD163 Expression to Inhibit PRRSV Infection via TLR4-NF-κB Pathway.
1/2016	Biotransformation of Daclatasvir In Vitro and in Nonclinical Species: Formation of the Main Metabolite by Pyrrolidine δ-Oxidation and Rearrangement.
2/2014	Inhibition of HSP90 attenuates porcine reproductive and respiratory syndrome virus production in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiaohong Liu Research Topics

Disease

73	Neoplasms (Cancer) 05/2024 - 01/2006
60	Infections 04/2024 - 10/2006
18	Inflammation (Inflammations) 03/2024 - 03/2007
11	Hepatocellular Carcinoma (Hepatoma) 10/2023 - 06/2008
10	Glaucoma 08/2022 - 11/2013
8	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2024 - 10/2007
7	Fibrosis (Cirrhosis) 11/2023 - 01/2014
7	Body Weight (Weight, Body) 01/2023 - 01/2015
7	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2012
6	Bites and Stings (Sting) 04/2024 - 01/2020
6	Pain (Aches) 01/2024 - 11/2015
6	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 01/2018
6	Wounds and Injuries (Trauma) 10/2023 - 12/2002
6	Type 2 Diabetes Mellitus (MODY) 10/2023 - 04/2008
6	Virus Diseases (Viral Diseases) 01/2023 - 02/2014
6	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 06/2019
6	COVID-19 01/2022 - 11/2020
5	Frailty 05/2024 - 07/2019
5	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2002
5	Carcinogenesis 01/2024 - 10/2007
5	Gestational Diabetes (Gestational Diabetes Mellitus) 06/2023 - 01/2021
5	Cognitive Dysfunction 11/2022 - 07/2016
5	Ocular Hypertension (Glaucoma, Suspect) 08/2022 - 06/2015
5	Myocardial Infarction 02/2022 - 01/2015
5	Human Influenza (Influenza) 01/2022 - 01/2017
5	Insulin Resistance 01/2021 - 04/2008
5	Obesity 01/2021 - 01/2012
4	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 12/2018
4	Pneumonia (Pneumonitis) 04/2024 - 12/2014
4	Infarction (Infarctions) 04/2024 - 01/2021
4	Porcine Reproductive and Respiratory Syndrome (PRRS) 03/2024 - 06/2010
4	Hypersensitivity (Allergy) 01/2024 - 04/2022
4	Asthma (Bronchial Asthma) 01/2024 - 01/2019
4	Cardiovascular Diseases (Cardiovascular Disease) 11/2023 - 01/2018
4	Hyperalgesia 01/2023 - 01/2019
4	Zika Virus Infection 01/2023 - 01/2018
4	Hypoglycemia (Reactive Hypoglycemia) 11/2022 - 06/2004
4	Lung Neoplasms (Lung Cancer) 01/2022 - 11/2015
4	Hyperglycemia 01/2022 - 01/2011
4	Hypertrophy 11/2021 - 01/2017
4	Hypertension (High Blood Pressure) 09/2021 - 07/2016
4	Stomach Neoplasms (Stomach Cancer) 11/2020 - 12/2014
4	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2020 - 01/2018
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2024 - 07/2020
3	Neuralgia (Stump Neuralgia) 01/2024 - 01/2021
3	Disease Progression 01/2024 - 01/2020
3	Adenocarcinoma of Lung 01/2024 - 01/2023
3	Carcinoma (Carcinomatosis) 01/2024 - 01/2014
3	Bacterial Infections (Bacterial Infection) 10/2023 - 10/2021

Drug/Important Bio-Agent (IBA)

32	Proteins (Proteins, Gene)FDA Link 11/2023 - 06/2008
19	CytokinesIBA 03/2024 - 06/2010
16	Antiviral Agents (Antivirals)IBA 04/2024 - 06/2010
14	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2016
12	Messenger RNA (mRNA)IBA 11/2023 - 12/2002
12	MicroRNAs (MicroRNA)IBA 11/2022 - 01/2012
11	VaccinesIBA 01/2023 - 06/2012
10	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2018
8	Glucose (Dextrose)FDA LinkGeneric 11/2023 - 06/2004
8	Retinaldehyde (Retinal)IBA 05/2022 - 03/2007
7	DNA (Deoxyribonucleic Acid)IBA 01/2024 - 09/2014
7	Therapeutic UsesIBA 01/2022 - 04/2014
6	LipidsIBA 04/2024 - 01/2011
6	Liposomes (Liposome)IBA 12/2023 - 01/2017
6	InflammasomesIBA 01/2023 - 01/2018
5	EnzymesIBA 04/2024 - 06/2010
5	AntioxidantsIBA 02/2024 - 01/2021
5	ChromatinIBA 02/2024 - 01/2018
5	Insulin (Novolin)FDA Link 10/2023 - 06/2004
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 12/2002
5	ProdrugsIBA 01/2023 - 05/2013
5	Long Noncoding RNAIBA 01/2022 - 01/2018
4	Neuroprotective AgentsIBA 04/2024 - 09/2015
4	CalciumIBA 01/2024 - 10/2015
4	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2020
4	Nonesterified Fatty Acids (NEFA)IBA 01/2024 - 01/2011
4	HydrogelsIBA 10/2023 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 03/2007
4	sodium bisulfide (NaHS)IBA 08/2022 - 01/2017
4	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 08/2022 - 01/2017
4	Blood Glucose (Blood Sugar)IBA 06/2021 - 06/2004
3	Interleukin-8 (Interleukin 8)IBA 03/2024 - 12/2002
3	Tyrosine Kinase InhibitorsIBA 03/2024 - 08/2016
3	Cyclic NucleotidesIBA 01/2024 - 01/2021
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 11/2010
3	InterferonsIBA 01/2024 - 01/2020
3	C-Reactive ProteinIBA 06/2023 - 01/2020
3	Adenosine Monophosphate (AMP)IBA 01/2023 - 01/2021
3	ICI D2788IBA 01/2023 - 01/2021
3	Olive OilIBA 01/2023 - 01/2019
3	Palmitic Acid (Hexadecanoic Acid)IBA 01/2023 - 06/2018
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 10/2015
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2023 - 06/2018
3	Interferon Type IIBA 01/2023 - 01/2022

Therapy/Procedure

44	Therapeutics 05/2024 - 06/2004
13	Drug Therapy (Chemotherapy) 11/2022 - 02/2008
7	Radiotherapy 01/2021 - 08/2016
5	Immunotherapy 04/2024 - 11/2020
5	Transplantation 01/2021 - 05/2012
4	Chemoradiotherapy 01/2020 - 02/2008
3	Phage Therapy 01/2023 - 10/2021